top of page

OUR MISSION

Abstract Background
Vaccine
Developing a new and improved vaccine targeting multiple developmental stages of Plasmodium falciparum.
Main goals

> Optimise the efficacy of current pre-erythrocytic vaccines while evaluating the safety and immunogenicity of new blood-stage mRNA vaccine candidates.

​

> Develop the next generation of highly efficacious malaria vaccine candidates using an advanced in-silico platform to analyse TCR- and single-cell sequencing data in combination with artificial intelligence (AI) based predictions of novel malaria vaccine antigens.

​

Establish a European facility for the production of malaria sporozoites for research and clinical use.

  • alt.text.label.LinkedIn
  • alt.text.label.Twitter
Captivate_Logo-web_240207.png

Join European Vaccine Initiative's (CAPTIVATE's project coordinator) mailing list for updates on projects, training and funding opportunities.

Thanks for subscribing!

EN_FundedbytheEU_RGB_PORTFOLIO.png

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

​

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101081028.

©2024 by European Vaccine Initiative

bottom of page